A new vaccine that boosts immunity against tuberculosis (TB) has been shown to be effective in pioneering pre-clinical trials.
Biologists have discovered a new type of RNA-splicing regulation that helps to determine which protein-coding exons will be included in messenger RNA transcripts.
Snopes tried to discredit research as a "rumor" when journalist received early results from conference call between researchers and study participants. Spike still detectable in some participants ...
Immune cell populations of people with post-vaccination syndrome had lower levels of effector CD4 T cells and higher levels ...
20h
AZoLifeSciences on MSNBreakthrough mRNA Technology Paves the Way for Precision MedicineImagine a breakthrough in cancer treatment where only malignant cells are targeted, sparing healthy host cells; or patients ...
In the fourth quarter, Repligen's performance was mixed. Adjusted earnings per share (EPS) surpassed analysts' expectations ...
A new mRNA vaccine against tuberculosis (TB) is showing favorable results in preclinical trials. With only one currently ...
A new vaccine that boosts immunity against tuberculosis (TB) has been shown to be effective in pioneering pre-clinical trials ...
US scientists have discovered an alarming syndrome linked to the most commonly used Covid jab in the UK as the number of ...
RNA splicing is crucial for gene expression. After DNA is copied into messenger RNA (mRNA), noncoding parts called introns are removed, and the coding parts are spliced together.
Over 200 years after the first successful vaccine was created by an English physician, who discovered that inoculation with the cowpox virus protected against smallpox, vaccines remain one of the […] ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results